Drug Delivery Systems for Metabolic Disorders

<p><br>1. Introduction to metabolic disorders<br>2. Cellular and molecular mechanisms involved in metabolic disorders<br>3. Current practices in drug delivery for metabolic disorders<br>4. Recent developments towards treatment of amyloidosis. <br>5. Advanced drug delivery systems targeting to improve therapeutic outcomes in Porphyria<br>6. Advanced drug delivery systems targeting Kwashiorkor involving disturbance in protein metabo-lism<br>7. Advanced drug delivery systems targeting metabolic disorders involving a disturbance in protein metabolism:  Erythropoietic Uroporphyria.<br>8. Combating Atherosclerosis with novel drug delivery approaches: From benchside to commerciali-zation<br>9. Advanced drug delivery systems in the management of Gaucher Disease<br>10. Advanced drug delivery systems focusing the metabolic disorders due to deregulation of lipid me-tabolism: Niemann Pick Disease & Letterer-Siwe disease<br>11. Novel Drug Delivery system to treat Niemann-Pick disease<br>12. Novel 3D printing drug delivery system for the prevention and treatment of Atherosclerosis<br>13. Advanced drug delivery systems to treat Huntington disease: Challenges and opportunities<br>14. Advanced Drug Delivery Systems for obesity <br>15. Advanced drug delivery systems probing the metabolic disorder due to deregulation in carbohy-drate metabolism<br>16. Advanced drug delivery systems dealing with metabolic disorder due to disturbance in hormone metabolism- hypoglycaemia and hyperglycemia,<br>17. EMERGING drug  delivery in the treatment of hyperpituitarism and hypopituitarism<br>18. Advanced drug deliver system dealing with metabolisn disorders due to disturbance in harmone metabolism  example Hypoparathyroidism and Hyperparathyroidism<br>19. An update on development of advanced drug delivery systems for treatment of hyperthyroidism<br>20. Advanced drug delivery systems involving lysosomal storage disorders for Schinder disease and other disorders<br>21. Advanced drug delivery systems involving lysosomal storage disorders for Fabry disease<br>22. Drug delivery systems in Krabbe Disease: Present and prospective approaches.<br>23. Advanced Treatment Strategies to combat  Tay-Sachs Disease (TSD)<br>24. Sandhoff Disease: Pathology and Advanced Treatment Strategies<br>25. Nanomaterial-based drug delivery approaches for metabolic disorders.<br>26. Eye in Metabolic Disorders: Manifestations and Drug Delivery Systems<br>27. Advanced drug delivery systems involving mitochondrial disorders <br>28. Application of phytoceuticals in targeting metabolic disorders<br>29. Phytonanoparticles towards the treatment of diabetes. <br>30. Role of Neutraceuticals in metabolic disorders<br>31. Latest Advances of phytomedicine in drug delivery systems for targeting metabolic disorders.<br>32. Clinical trials, future prospects and challenges of drug delivery in combating metabolic disorders</p>